Company
Headquarters: Fukuoka, Japan
Employees: 4,872
¥507.72 Billion
JPY as of Jan. 1, 2025
US$3.24 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.
| Last Financial Reports Date | May 31, 2024 |
| Revenue TTM | ¥985.18 B |
| EBITDA | ¥34.40 B |
| Gross Profit TTM | ¥188.31 B |
| Profit Margin | 2.65% |
| Operating Margin | 4.38% |
| Quarterly Revenue Growth | 8.40% |
COSMOS Pharmaceutical Corp has the following listings and related stock indices.
Stock: JPX: 3349 wb_incandescent